Skip to search formSkip to main contentSkip to account menu

C1 esterase inhibitor (recombinant) 2100 UNT Injection [Ruconest]

Known as: CONESTAT ALFA 2100 U INTRAVENOUS INJECTION, POWDER, FOR SOLUTION [Ruconest], Ruconest 2100 UNT Injection 
National Institutes of Health

Related topics

Related topics

6 relations
C1 esterase inhibitor (recombinant)InjectionRuconestSucrose

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Cost-utility analysis of Ruconest® (conestat alfa) compared to Berinert® P (human C1 esterase inhibitor) in the treatment of acute, life-threatening angioedema attacks in patients with hereditary…
Introduction Administration of human C1 esterase inhibitor (Berinert® P) from target import is the most widespread treatment… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)